Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cempra Inc (NASDAQ:CEMP)

During the Trading Day
33.43 -0.97 / -2.82%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
33.43 0.00 / 0.00%
Volume: 6.5K
Health Technology
Pharmaceuticals: Other

Company Description

Cempra, Inc. is a clinical-stage pharmaceutical company. It focuses on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. The company intends to utilize its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. It has two antibiotic candidates: Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC.

Contact Information

Cempra, Inc.
Building Two Quadrangle
Chapel Hill North Carolina 27517
P:(919) 313-6601
Investor Relations:



Mutual fund holders34.93%
Individual stakeholders26.31%
Other institutional26.05%

Top Executives

Prabhavathi B. FernandesPresident, Chief Executive Officer & Director
Mark W. HahnChief Financial Officer & Executive Vice President
David OldachChief Medical Officer
David S. MooreChief Commercial Officer & Executive VP
David PereiraSenior Vice President